4 Things Exact Sciences Investors Should Know About 23andMe's New Cancer Test

It's been more than five years since the Food and Drug Administration stopped allowing 23andMe to tell customers about the cancer risks they inherited. Last year, the agency began allowing the company to offer risk assessments for breast cancer and, more recently, colorectal cancer.